4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-138541
Chief Financial Officer sold 20,000 shares at $8.00 ($160,000)
- Chief Financial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2016-08-22 | Option exercise | +13,100 | $2.01 | $26,331 | 128,789 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2016-08-22 | Sale | −13,100 | $8.00 | $104,800 | 115,689 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2016-08-23 | Option exercise | +6,900 | $2.01 | $13,869 | 122,589 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2016-08-23 | Sale | −6,900 | $8.00 | $55,200 | 115,689 | D |
| Derivatives | |||||||
| Myszkowski Kenneth Allen Chief Financial Officer | 2016-08-22 | Option exercise · Stock Option (right to buy) | −13,100 | 348,900 | D | ||
| Myszkowski Kenneth Allen Chief Financial Officer | 2016-08-23 | Option exercise · Stock Option (right to buy) | −6,900 | 342,000 | D | ||
| Open-market sales · 20,000 sh · avg $8.00 · $160,000 | |||||||
Loading xslF345X03/doc4.xml…